A borrower repays Rs 2 crore of its term loan ahead of schedule. The credit file notes: “prepayment of Rs 2 crore received. Account health: strong. Borrower demonstrates commitment to debt reduction.”
The Fresh-Money Repayment Test asks where the Rs 2 crore came from. If it came from operating cash flow accumulated over several quarters, the prepayment is a genuine signal of financial health. If it came from a new borrowing, a promoter infusion funded by personal debt, a one-time asset sale or a group entity transfer, the prepayment is a liquidity event, not a performance signal.
Why the source of repayment matters
A repayment funded by operating cash flow confirms that the business generates sufficient cash after funding its operations, its working capital and its maintenance requirements to reduce its debt burden. This is the best-case signal: the business is performing well enough to deleverage.
A repayment funded by new borrowing is debt substitution, not debt reduction. The borrower has not deleveraged. It has re-leveraged with a different lender. The total debt has not changed. The lender who received the repayment records it as a reduction. The lender who disbursed the new borrowing records it as a new exposure. The borrower’s aggregate debt is the same.
A repayment funded by asset sales is a one-time event. The borrower sold a property, a vehicle fleet, a subsidiary or a non-core business unit and used the proceeds to reduce debt. The deleveraging is real, but it is not repeatable. The asset has been consumed. If the borrower’s operating cash flow has not improved, the debt will rebuild because the structural deficit remains.
A repayment funded by promoter infusion may indicate promoter commitment, or it may indicate that the promoter is pulling cash from other sources (personal borrowing, other business interests, family assets) to maintain the appearance of a performing account. The motivation matters: is the promoter investing in a business it believes in, or is the promoter preventing a default that would trigger personal guarantee enforcement?
The source-of-funds analysis
Step 1: Track the cash. Examine the borrower’s bank statements for the 30 days preceding the repayment. Where did the Rs 2 crore come from?
If the account balance grew gradually over the preceding months from operating receipts (customer payments in the normal course), the repayment is operating-cash-funded. This is the clean scenario.
If a large, unusual credit appeared in the account shortly before the repayment (an NBFC disbursement, a transfer from a group entity, a credit from the promoter’s personal account, proceeds from an asset sale), the repayment is event-funded. The event must be understood before the repayment is interpreted.
Step 2: Trace the event. If the funding source was an NBFC disbursement, determine: was the NBFC facility disclosed to the primary lender? Was it sanctioned after the primary facility? Is the NBFC’s facility effectively subordinate to the primary lender’s facility, or does it share security? The borrower has reduced its exposure to one lender by increasing its exposure to another. The aggregate debt burden on the business has not changed.
If the funding source was a promoter infusion, determine: where did the promoter get the Rs 2 crore? If the promoter sold personal investments or property, the infusion is a genuine contribution. If the promoter borrowed Rs 2 crore from a private lender (secured against personal assets), the infusion is a loan disguised as equity. The business now has an additional obligation (repaying the promoter, who must repay the private lender).
If the funding source was a group entity transfer, determine: was the transfer a loan or a capital infusion? Does the group entity have the financial capacity to make the transfer, or did the group entity borrow to make the transfer (cascading the debt up the group structure)? Is there an expectation of repayment (in which case the borrower has a new liability)?
If the funding source was an asset sale, determine: what was sold? Was it a core asset (the sale may impair future earning capacity) or a non-core asset (the sale is a genuine monetisation)? Was the sale to a genuine third party at arm’s length, or to a connected entity (which may be a dressed-up intercompany transfer rather than a genuine monetisation)?
Step 3: Recalculate the borrower’s actual debt position. After tracing the source, the borrower’s actual debt is recalculated:
If the Rs 2 crore repayment was funded by a new Rs 2 crore NBFC borrowing, the total debt has not changed. The primary lender’s exposure decreased by Rs 2 crore. The total exposure (across all lenders) remained the same. The deleveraging is an illusion.
If the Rs 2 crore repayment was funded by operating cash flow and the total debt declined by Rs 2 crore across all lenders, the deleveraging is real.
The distinction is critical for the lender’s portfolio assessment, covenant evaluation and risk rating. A genuine prepayment improves the account’s risk profile. A debt-substitution prepayment does not.
What the lender receives
A source-of-repayment analysis for every material prepayment, partial repayment or significant principal reduction: the amount, the source of funds (traced through bank statements), the nature of the source (operating cash, new borrowing, asset sale, promoter infusion, group entity transfer), the impact on total debt (across all lenders, not just the primary lender) and the conclusion (genuine deleveraging or debt substitution).
The analysis is particularly important at renewal time. A borrower that has “reduced its exposure by Rs 2 crore” looks stronger at renewal. A borrower that has substituted the exposure with NBFC debt and a promoter loan is not stronger. It has the same total debt with a more complex capital structure and a potentially more expensive cost of funds (NBFC rates typically exceed bank rates, and the promoter’s personal borrowing carries its own cost).
The Fresh-Money Repayment Test ensures the lender’s credit assessment reflects the actual debt position, not the apparent one.